- Home
- CPRX vs RUN Comparison
CPRX vs RUN Comparison
Compare CPRX & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- RUN
- Stock Information
- Founded
- CPRX 2002
- RUN 2007
- Country
- CPRX United States
- RUN United States
- Employees
- CPRX N/A
- RUN N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- RUN Industrial Machinery/Components
- Sector
- CPRX Health Care
- RUN Miscellaneous
- Exchange
- CPRX Nasdaq
- RUN Nasdaq
- Market Cap
- CPRX 2.6B
- RUN 2.4B
- IPO Year
- CPRX 2006
- RUN 2015
- Fundamental
- Price
- CPRX $20.59
- RUN $15.97
- Analyst Decision
- CPRX Strong Buy
- RUN Buy
- Analyst Count
- CPRX 5
- RUN 20
- Target Price
- CPRX $33.20
- RUN $16.12
- AVG Volume (30 Days)
- CPRX 1.5M
- RUN 19.2M
- Earning Date
- CPRX 08-06-2025
- RUN 08-06-2025
- Dividend Yield
- CPRX N/A
- RUN N/A
- EPS Growth
- CPRX 183.96
- RUN N/A
- EPS
- CPRX 1.65
- RUN N/A
- Revenue
- CPRX $558,499,000.00
- RUN $2,129,272,000.00
- Revenue This Year
- CPRX $16.51
- RUN $11.84
- Revenue Next Year
- CPRX $9.58
- RUN $8.69
- P/E Ratio
- CPRX $12.45
- RUN N/A
- Revenue Growth
- CPRX 28.55
- RUN 3.27
- 52 Week Low
- CPRX $19.00
- RUN $5.38
- 52 Week High
- CPRX $26.58
- RUN $21.77
- Technical
- Relative Strength Index (RSI)
- CPRX 48.79
- RUN 65.32
- Support Level
- CPRX $19.83
- RUN $15.77
- Resistance Level
- CPRX $21.82
- RUN $16.90
- Average True Range (ATR)
- CPRX 0.57
- RUN 1.26
- MACD
- CPRX 0.07
- RUN 0.19
- Stochastic Oscillator
- CPRX 45.33
- RUN 86.32
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.